These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 27806648

  • 1. Synthesis and biological evaluation of novel N1-phenylsulphonyl indole derivatives as potent and selective 5-HT6R ligands for the treatment of cognitive disorders.
    Nirogi RV, Bandyala TR, Gangadasari PR, Khagga M.
    J Enzyme Inhib Med Chem; 2016; 31(sup1):1-15. PubMed ID: 27806648
    [Abstract] [Full Text] [Related]

  • 2. Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
    Kołaczkowski M, Marcinkowska M, Bucki A, Śniecikowska J, Pawłowski M, Kazek G, Siwek A, Jastrzębska-Więsek M, Partyka A, Wasik A, Wesołowska A, Mierzejewski P, Bienkowski P.
    Eur J Med Chem; 2015 Mar 06; 92():221-35. PubMed ID: 25557493
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N₁-arylsulfonyl indole derivatives as 5-HT₆ receptor ligands.
    Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M.
    Bioorg Med Chem Lett; 2012 Dec 15; 22(24):7431-5. PubMed ID: 23141912
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, docking and pharmacological evaluation of novel homo- and hetero-bis 3-piperazinylpropylindole derivatives at SERT and 5-HT1A receptor.
    Pessoa-Mahana H, González-Lira C, Fierro A, Zapata-Torres G, Pessoa-Mahana CD, Ortiz-Severin J, Iturriaga-Vásquez P, Reyes-Parada M, Silva-Matus P, Saitz-Barría C, Araya-Maturana R.
    Bioorg Med Chem; 2013 Dec 15; 21(24):7604-11. PubMed ID: 24262884
    [Abstract] [Full Text] [Related]

  • 5. Novel difluoromethylated 1-(phenylsulfonyl)-4-(piperazin-1-yl)-1H-indole derivatives as potent 5-HT6 receptor antagonist with AMDE-improving properties: Design, synthesis, and biological evaluation.
    Yi C, Chen K, Liang H, Wang Z, Wang T, Li K, Yu J, Sun J, Jin C.
    Bioorg Med Chem; 2022 Oct 01; 71():116950. PubMed ID: 35926324
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and in vitro Evaluation of Novel Indole-Based Sigma Receptors Ligands.
    Yarim M, Koksal M, Schepmann D, Wünsch B.
    Chem Biol Drug Des; 2011 Nov 01; 78(5):869-75. PubMed ID: 21848665
    [Abstract] [Full Text] [Related]

  • 7. Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.
    Nirogi R, Dwarampudi A, Kambhampati R, Bhatta V, Kota L, Shinde A, Badange R, Jayarajan P, Bhyrapuneni G, Dubey PK.
    Bioorg Med Chem Lett; 2011 Aug 01; 21(15):4577-80. PubMed ID: 21724392
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists.
    Cole DC, Ellingboe JW, Lennox WJ, Mazandarani H, Smith DL, Stock JR, Zhang G, Zhou P, Schechter LE.
    Bioorg Med Chem Lett; 2005 Jan 17; 15(2):379-83. PubMed ID: 15603958
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Design, synthesis and preliminary screening of novel 3-(2-N,N-dimethylaminoethylthio) indole derivatives as potential 5-HT(6) receptor ligands.
    Kambhampati R, Konda J, Reballi V, Shinde AK, Dubey PK, Nirogi RV.
    J Enzyme Inhib Med Chem; 2008 Jun 17; 23(3):302-12. PubMed ID: 18569332
    [Abstract] [Full Text] [Related]

  • 13. Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer's Disease.
    Nirogi R, Shinde A, Kambhampati RS, Mohammed AR, Saraf SK, Badange RK, Bandyala TR, Bhatta V, Bojja K, Reballi V, Subramanian R, Benade V, Palacharla RC, Bhyrapuneni G, Jayarajan P, Goyal V, Jasti V.
    J Med Chem; 2017 Mar 09; 60(5):1843-1859. PubMed ID: 28212021
    [Abstract] [Full Text] [Related]

  • 14. Novel difluoromethyl-containing 1-((4-methoxy-3-(piperazin-1-yl)phenyl)sulfonyl)-1H-indole scaffold as potent 5-HT6R antagonists: Design, synthesis, biological evaluation, and early in vivo cognition-enhancing studies.
    Yi C, Xue Y, Chen K, Wang T, Yu J, Wang Z, Jin C.
    Bioorg Med Chem; 2022 Sep 15; 70():116917. PubMed ID: 35839536
    [Abstract] [Full Text] [Related]

  • 15. Design and synthesis of novel series of 5-HT6 receptor ligands having indole, a central aromatic core and 1-amino-4 methyl piperazine as a positive ionizable group.
    Hayat F, Cho S, Rhim H, Indu Viswanath AN, Pae AN, Lee JY, Choo DJ, Choo HY.
    Bioorg Med Chem; 2013 Sep 01; 21(17):5573-82. PubMed ID: 23810425
    [Abstract] [Full Text] [Related]

  • 16. 4-(2-Aminoethoxy)-N-(phenylsulfonyl)indoles as novel 5-HT6 receptor ligands.
    Zhou P, Yan Y, Bernotas R, Harrison BL, Huryn D, Robichaud AJ, Zhang GM, Smith DL, Schechter LE.
    Bioorg Med Chem Lett; 2005 Mar 01; 15(5):1393-6. PubMed ID: 15713394
    [Abstract] [Full Text] [Related]

  • 17. Indole-3-piperazinyl derivatives: novel chemical class of 5-HT(6) receptor antagonists.
    Nirogi RV, Deshpande AD, Kambhampati R, Badange RK, Kota L, Daulatabad AV, Shinde AK, Ahmad I, Kandikere V, Jayarajan P, Dubey PK.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):346-9. PubMed ID: 21134749
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, structure-activity relationships, and biological properties of 1-heteroaryl-4-[omega-(1H-indol-3-yl)alkyl]piperazines, novel potential antipsychotics combining potent dopamine D2 receptor antagonism with potent serotonin reuptake inhibition.
    Smid P, Coolen HK, Keizer HG, van Hes R, de Moes JP, den Hartog AP, Stork B, Plekkenpol RH, Niemann LC, Stroomer CN, Tulp MT, van Stuivenberg HH, McCreary AC, Hesselink MB, Herremans AH, Kruse CG.
    J Med Chem; 2005 Nov 03; 48(22):6855-69. PubMed ID: 16250644
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.